Home » Topics » Regulatory

Regulatory
RSS

Australia first to approve Xolair

June 21, 2002

FDA approves Celebrex labeling changes

June 18, 2002

Japanese approval obtained for Elaspol

June 18, 2002

Extina enters phase III for seborrheic dermatitis

June 17, 2002

Zyprexa approved in E.U. for manic episodes associated with bipolar disorder

June 17, 2002

Phase II results announced for Ciprofloxacin GR

June 14, 2002

FDA approves Ritalin LA for ADHD

June 10, 2002

New indications approved for desloratadine in E.U.

June 7, 2002

CPMP recommends approval of ARANESP for anemia in cancer patients

June 5, 2002

Vyteris submits NDA for lidocaine patch

June 5, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 24, 2026.
To viral or not to viral: In vivo CAR T debates delivery tech
BioWorld
The field of cell and gene therapy is moving toward a new phase of scalability and clinical durability, with in vivo chimeric antigen receptor (CAR) T-cell...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 21, 2026
KBN-2201 reverses key features of Alzheimer’s in mice
BioWorld Science
Researchers from Ajou University School of Medicine reported the preclinical efficacy of KBN-2201 in a mouse model of late-stage Alzheimer’s disease.
In vivo click ADCs could address tumor heterogeneity
BioWorld
Researchers at Washington University in St. Louis have used click chemistry to link a second antibody to a pre-existing antibody-drug conjugate (ADC) in vivo. In...